Loyal
Loyal (Cellular Longevity, Inc.) is a clinical-stage veterinary biotechnology company developing drugs intended to extend the healthy lifespan of dogs. Its lead programs — including LOY-002 for metabolic dysfunction in senior dogs and LOY-001/LOY-003 for large- and giant-breed dogs — are advancing through the FDA Center for Veterinary Medicine approval process, with more than 1,300 dogs enrolled across clinical studies. Loyal also runs a veterinary Learning Hub for practitioner education. The company is backed by Bain Capital Ventures and First Round Capital. As of this enrichment pass Loyal publishes no public developer API, OpenAPI/AsyncAPI specification, SDK, MCP server, or /.well-known discovery surface; this profile captures its public web identity and a live domain-security probe.
Loyal is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Veterinary, and Animal Health.
Loyal’s developer surface includes engineering blog, support, and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API